Amgen Stock Climbs as Drug Growth Outruns Obesity Setback
Amgen Stock Climbs as Drug Growth Outruns Obesity Setback Yahoo Finance UK
Covered in this story
Summary aggregated from Yahoo Finance UK's public RSS feed. The full reporting belongs to Yahoo Finance UK — please read it on their site.